3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Burkitt Lymphoma
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Down Syndrome
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Biphenotypic, Acute
1
Leukemia
1
Interventions
Tretinoin
2
Arsenic Trioxide
2
arsenous acid
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Lisaftoclax
1
Idarubicin
1
Gemtuzumab
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia, Promyelocytic, Acute
×
Mercaptopurine
×
30 days
×
Clear all
NCT02688140
2026-05-29
TUD-APOLLO-064
Technische Universität Dresden
Phase 3
Completed
133 enrolled